tm logo
KYVERNA
Live/Registered
REGISTERED

on 14 Nov 2023

Last Applicant/ Owned by

5980 Horton Street

Emeryville

CA

94608

Serial Number

88639742 filed on 02th Oct 2019

Registration Number

7219011 registered on 14th Nov 2023

in the Principal Register

Correspondent Address

Lisa Greenwald-Swire

FISH & RICHARDSON P.C.

P.O. BOX 1022

MINNEAPOLIS, MN 55440-1022

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

KYVERNA

The English translation of the word "KYVERNA" in the mark is "GOVERN" or "RULE". Therapeutic pharmaceutical for the treatment of autoimmune disease; therapeutic pharmaceuticals and cell therapy products in the nature of cells for medical or clinical use for the treatment of autoimmune disease; cell therapy products, namely, genetically engineered immune cells for medical or clinical use for the tRead More

Classification Information


Class [005]
Pharmaceutical Products


Therapeutic pharmaceutical for the treatment of autoimmune disease; therapeutic pharmaceuticals and cell therapy products in the nature of cells for medical or clinical use for the treatment of autoimmune disease; cell therapy products, namely, genetically engineered immune cells for medical or clinical use for the treatment of autoimmune disease


First Use Date in General

19th Sep 2023

First Use Date in Commerce

19th Sep 2023

Mark Details


Serial Number

No 88639742

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 479020013001

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
14th Nov 2023REGISTERED-PRINCIPAL REGISTER
14th Nov 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
07th Oct 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06th Oct 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
26th Sep 2023STATEMENT OF USE PROCESSING COMPLETE
22nd Sep 2023TEAS STATEMENT OF USE RECEIVED
22nd Sep 2023USE AMENDMENT FILED
30th Mar 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
29th Mar 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
29th Mar 2023SOU EXTENSION 5 GRANTED